Immunotherapy | Tumor

Establishing a Plan for Treatment

January 11th 2018, 11:47pm

Characterizing the Types of Breast Cancer

January 11th 2018, 11:47pm

Combinations May Be the Future of Immunotherapy in Ovarian Cancer

January 10th 2018, 8:00pm

To date, trials testing the use of immunotherapy in the treatment of ovarian cancer yielded disappointing results. However, researchers are not giving up. Instead, they’re investigating to see if immunotherapy drugs – such as PD1 and PDL-1 inhibitors – can be combined with other agents to benefit patients.

Examining the Role of Biomarkers in the Management of Non-Small Cell Lung Cancer

December 29th 2017, 10:33pm

Ferdinandos Skoulidis, M.D., Ph.D. highlights potential treatment options for KRAS-mutated lung cancer and explores developments in biomarker research in other areas in the field.

Will Immunotherapy and Radiation Be Combined in Lung Cancer Treatment?

December 27th 2017, 9:03pm

Checkpoint inhibitors continue to show promise in the treatment of patients with non-small cell lung cancer (NSCLC), but researchers are now exploring the efficacy of these agents when combined with radiation therapy (RT).

Combination Immunotherapy Shows Promise for Bladder Cancer

December 26th 2017, 10:40pm

When combined with other regimens in the treatment of patients with bladder cancer, immunotherapy has been shown to be beneficial, according to Arjun Balar, M.D.

A Cancer Journey Reflection

December 21st 2017, 11:11pm

Extending Remission in Ovarian Cancer

December 21st 2017, 11:11pm

Role for PARP Inhibitors as Maintenance Therapy

December 21st 2017, 11:11pm

Ovarian Cancer: How PARP Inhibitors Work

December 21st 2017, 11:11pm